Current CDC travel health notices show no active Level 4 advisories, with recent alerts limited to Level 1 or 2 for Ebola outbreaks in the Democratic Republic of the Congo and Uganda, global dengue, polio across 30 locations, and rising U.S. measles cases. Official epidemiological data indicate contained transmission rates and case counts below historical thresholds that previously triggered “Avoid All Travel” designations, supporting trader consensus around a 78% probability for no issuance by year-end. Routine surveillance updates from the CDC and WHO, along with any confirmed surges in hantavirus or novel strains, represent key upcoming data points that could shift market-implied odds if they exceed established risk criteria.
Polymarket 데이터를 참조하는 실험적 AI 생성 요약입니다. 이것은 거래 조언이 아니며 이 마켓의 정산에 영향을 미치지 않습니다. · 업데이트예
$71,630 거래량
$71,630 거래량
2026.12.31
예
$71,630 거래량
$71,630 거래량
2026.12.31
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Current CDC travel health notices show no active Level 4 advisories, with recent alerts limited to Level 1 or 2 for Ebola outbreaks in the Democratic Republic of the Congo and Uganda, global dengue, polio across 30 locations, and rising U.S. measles cases. Official epidemiological data indicate contained transmission rates and case counts below historical thresholds that previously triggered “Avoid All Travel” designations, supporting trader consensus around a 78% probability for no issuance by year-end. Routine surveillance updates from the CDC and WHO, along with any confirmed surges in hantavirus or novel strains, represent key upcoming data points that could shift market-implied odds if they exceed established risk criteria.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
마켓 개설일: Jan 19, 2026, 3:15 PM ET
거래량
$71,630종료일
2026.12.31마켓 개설일
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Current CDC travel health notices show no active Level 4 advisories, with recent alerts limited to Level 1 or 2 for Ebola outbreaks in the Democratic Republic of the Congo and Uganda, global dengue, polio across 30 locations, and rising U.S. measles cases. Official epidemiological data indicate contained transmission rates and case counts below historical thresholds that previously triggered “Avoid All Travel” designations, supporting trader consensus around a 78% probability for no issuance by year-end. Routine surveillance updates from the CDC and WHO, along with any confirmed surges in hantavirus or novel strains, represent key upcoming data points that could shift market-implied odds if they exceed established risk criteria.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
거래량
$71,630종료일
2026.12.31마켓 개설일
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Current CDC travel health notices show no active Level 4 advisories, with recent alerts limited to Level 1 or 2 for Ebola outbreaks in the Democratic Republic of the Congo and Uganda, global dengue, polio across 30 locations, and rising U.S. measles cases. Official epidemiological data indicate contained transmission rates and case counts below historical thresholds that previously triggered “Avoid All Travel” designations, supporting trader consensus around a 78% probability for no issuance by year-end. Routine surveillance updates from the CDC and WHO, along with any confirmed surges in hantavirus or novel strains, represent key upcoming data points that could shift market-implied odds if they exceed established risk criteria.
Polymarket 데이터를 참조하는 실험적 AI 생성 요약입니다. 이것은 거래 조언이 아니며 이 마켓의 정산에 영향을 미치지 않습니다. · 업데이트
외부 링크에 주의하세요.
외부 링크에 주의하세요.
자주 묻는 질문